Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition
Intravesical BCG instillation after bladder tumor resection is the standard treatment for non-muscle invasive bladder cancer; however, it is not always effective and frequently has undesirable side effects. Therefore, new strategies that improve the clinical management of patients are urgently neede...
Main Authors: | Jordi Senserrich, Sandra Guallar-Garrido, Elisabet Gomez-Mora, Victor Urrea, Bonaventura Clotet, Esther Julián, Cecilia Cabrera |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.993401/full |
Similar Items
-
Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
by: Jorge Carrillo, et al.
Published: (2018-10-01) -
Mendelian susceptibility to mycobacterial infection in man
by: J-L Casanova
Published: (2001-08-01) -
A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01) -
Use of antiviral drugs to reduce COVID-19 transmission
by: Oriol Mitjà, et al.
Published: (2020-05-01) -
Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect
by: Sandra Guallar-Garrido, et al.
Published: (2020-05-01)